Recommendations for diagnosis and treatment of systemic lupus erythematosus.
10.3760/cma.j.cn112138-20221027-00793
- Author:
Nan SHEN
1
;
Yi ZHAO
2
;
Li Hua DUAN
3
;
Li Jun SONG
4
;
Xiao Feng ZENG
5
;
Yi LIU
2
;
Yan ZHAO
5
Author Information
1. Department of Rheumatology, Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai 200001, China.
2. Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China.
3. Department of Rheumatology and Clinical Immunology, Jiangxi Provincial People's Hospital, Nanchang 330006, China.
4. Department of Rheumatology, Qilu Hospital of Shandong University, Jinan 250100, China.
5. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Lupus Erythematosus, Systemic/complications*;
Prognosis;
Rheumatology;
China;
Severity of Illness Index
- From:
Chinese Journal of Internal Medicine
2023;62(7):775-784
- CountryChina
- Language:Chinese
-
Abstract:
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with complicated pathogenesis and diverse clinical manifestations. The current recommendations of the Chinese Rheumatology Association are based on a comprehensive investigation of evidence based medicine, domestic and international guidelines for SLE, and experts' proposals, and aim to provide a more scientific and authoritative reference for the diagnosis and management of SLE. The recommendations focus on four aspects; clinical manifestations, laboratory evaluation, diagnosis and disease assessment, and disease treatment and monitoring. The goal of the recommendations is to standardize the diagnosis and treatment of SLE in China so as to improve the prognosis of SLE patients.
